West Europe
United Kingdom· ReadingUK Regulatory Body Withdraws Chikungunya Vaccine Due to Safety Concerns
The MHRA has withdrawn the chikungunya vaccine due to reports of serious adverse reactions, including neurological conditions and deaths, drawing parallels to COVID-19 vaccines.
Background
Public health bodies globally monitor vaccine safety closely. In the UK, the MHRA is responsible for ensuring medicines and medical devices are safe and effective. Concerns about vaccine side effects, particularly following the COVID-19 pandemic, have led to increased public scrutiny and debate.
Quorum · collective opinions
UK Regulatory Body Withdraws Chikungunya Vaccine Due to Safety Concerns
First report 7h agoLast update 7h ago1 takes 1
vaccine risks outweigh benefitsneutralShow 1 post
started 7h ago•Last update 7h ago
The chikungunya vaccine has been withdrawn because its risks, including neurological issues and fatalities, are deemed to outweigh its benefits.
iWitness comments
No comments yet — be the first to weigh in.